BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16195327)

  • 1. Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4.
    Kardinal C; Dangers M; Kardinal A; Koch A; Brandt DT; Tamura T; Welte K
    Blood; 2006 Feb; 107(3):1133-40. PubMed ID: 16195327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4.
    Larrea MD; Liang J; Da Silva T; Hong F; Shao SH; Han K; Dumont D; Slingerland JM
    Mol Cell Biol; 2008 Oct; 28(20):6462-72. PubMed ID: 18710949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphatase SHP-2 is a regulator of p27(Kip1) tyrosine phosphorylation.
    Tossidou I; Dangers M; Koch A; Brandt DT; Schiffer M; Kardinal C
    Cell Cycle; 2008 Dec; 7(24):3858-68. PubMed ID: 19066472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells.
    Patel P; Tsiperson V; Gottesman SRS; Somma J; Blain SW
    Mol Cancer Res; 2018 Mar; 16(3):361-377. PubMed ID: 29330290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity.
    James MK; Ray A; Leznova D; Blain SW
    Mol Cell Biol; 2008 Jan; 28(1):498-510. PubMed ID: 17908796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
    Grimmler M; Wang Y; Mund T; Cilensek Z; Keidel EM; Waddell MB; Jäkel H; Kullmann M; Kriwacki RW; Hengst L
    Cell; 2007 Jan; 128(2):269-80. PubMed ID: 17254966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
    Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
    Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis.
    Coulonval K; Bockstaele L; Paternot S; Dumont JE; Roger PP
    Exp Cell Res; 2003 Nov; 291(1):135-49. PubMed ID: 14597415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited redundancy in phosphorylation of retinoblastoma tumor suppressor protein by cyclin-dependent kinases in acute lymphoblastic leukemia.
    Schmitz NM; Hirt A; Aebi M; Leibundgut K
    Am J Pathol; 2006 Sep; 169(3):1074-9. PubMed ID: 16936279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases.
    Bencivenga D; Tramontano A; Borgia A; Negri A; Caldarelli I; Oliva A; Perrotta S; Della Ragione F; Borriello A
    Cell Cycle; 2014; 13(23):3768-82. PubMed ID: 25483085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways.
    Le XF; Pruefer F; Bast RC
    Cell Cycle; 2005 Jan; 4(1):87-95. PubMed ID: 15611642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal phosphorylation controls the stability and function of p27kip1.
    Kossatz U; Vervoorts J; Nickeleit I; Sundberg HA; Arthur JS; Manns MP; Malek NP
    EMBO J; 2006 Nov; 25(21):5159-70. PubMed ID: 17053782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
    Min YH; Cheong JW; Kim JY; Eom JI; Lee ST; Hahn JS; Ko YW; Lee MH
    Cancer Res; 2004 Aug; 64(15):5225-31. PubMed ID: 15289327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anticancer activity of the substituted pyridone-annelated isoindigo (5'-Cl) involves G0/G1 cell cycle arrest and inactivation of CDKs in the promyelocytic leukemia cell line HL-60.
    Saleh AM; Aljada A; El-Abadelah MM; Taha MO; Sabri SS; Zahra JA; Aziz MA
    Cell Physiol Biochem; 2015; 35(5):1943-57. PubMed ID: 25870953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal-spatial expressions of p27kip1 and its phosphorylation on Serine-10 after acute spinal cord injury in adult rat: Implications for post-traumatic glial proliferation.
    Shen A; Liu Y; Zhao J; Qin J; Shi S; Chen M; Gao S; Xiao F; Lu Q; Cheng C
    Neurochem Int; 2008 May; 52(6):1266-75. PubMed ID: 18319192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
    Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
    Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPM/ALK downregulates p27Kip1 in a PI-3K-dependent manner.
    Slupianek A; Skorski T
    Exp Hematol; 2004 Dec; 32(12):1265-71. PubMed ID: 15588951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p21Cip1 or p27Kip1 in the promyelocytic leukemia cell line HL60 accelerates its lineage-specific differentiation.
    Zhou P; Yao Y; Soh JW; Weinstein IB
    Anticancer Res; 1999; 19(6B):4935-45. PubMed ID: 10697493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.